Bipin Sethi

1.9k total citations · 1 hit paper
44 papers, 1.2k citations indexed

About

Bipin Sethi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Bipin Sethi has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Bipin Sethi's work include Diabetes Treatment and Management (25 papers), Diabetes Management and Research (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Bipin Sethi is often cited by papers focused on Diabetes Treatment and Management (25 papers), Diabetes Management and Research (23 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers). Bipin Sethi collaborates with scholars based in India, Denmark and United Kingdom. Bipin Sethi's co-authors include Slobodan Antić, Rafael Simó, Allan Vaag, Nebojša Lalić, O. Schmitz, David Russell‐Jones, Marija Zdravković, Sanjay Kalra, Shashank Joshi and Banshi Saboo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Diabetologia.

In The Last Decade

Bipin Sethi

39 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

2009 688 citations David Russell‐Jones, Allan Vaag et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bipin Sethi India	12	952	485	313	198	89	44	1.2k
Francis C. C. Chow Hong Kong	14	765 0.8×	369 0.8×	247 0.8×	107 0.5×	112 1.3×	28	1.1k
Francis Chun Chung Chow Hong Kong	11	661 0.7×	296 0.6×	187 0.6×	127 0.6×	67 0.8×	16	855
Matthew P. Gilbert United States	13	619 0.7×	380 0.8×	242 0.8×	105 0.5×	72 0.8×	50	993
Anne Bloch Thomsen Denmark	15	1.3k 1.3×	691 1.4×	473 1.5×	337 1.7×	90 1.0×	25	1.5k
Kenneth E. Robertson United States	11	873 0.9×	457 0.9×	259 0.8×	180 0.9×	67 0.8×	14	1.0k
Ludger Rose Germany	15	1.3k 1.4×	573 1.2×	450 1.4×	241 1.2×	53 0.6×	33	1.5k
Heidrun Bosch‐Traberg Denmark	14	1.2k 1.3×	462 1.0×	425 1.4×	286 1.4×	157 1.8×	25	1.5k
Cesare Berra Italy	16	530 0.6×	249 0.5×	197 0.6×	101 0.5×	83 0.9×	40	860
Albert Fung United States	13	1.2k 1.3×	534 1.1×	587 1.9×	255 1.3×	68 0.8×	16	1.4k
Kerensa Thorne United Kingdom	6	965 1.0×	239 0.5×	217 0.7×	84 0.4×	150 1.7×	13	1.4k

Countries citing papers authored by Bipin Sethi

Since Specialization

Citations

This map shows the geographic impact of Bipin Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bipin Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bipin Sethi more than expected).

Fields of papers citing papers by Bipin Sethi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bipin Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bipin Sethi. The network helps show where Bipin Sethi may publish in the future.

Co-authorship network of co-authors of Bipin Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of Bipin Sethi. A scholar is included among the top collaborators of Bipin Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bipin Sethi. Bipin Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sethi, Bipin, Krishna Seshadri, Vaishali Deshmukh, et al.. (2024). Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient Program. Cureus. 16(11). e73093–e73093.

Das, Ashok Kumar, Sanjay Kalra, Shashank Joshi, et al.. (2023). The LongitudinAl Nationwide stuDy on Management And Real‐world outComes of diabetes in India over 3 years (LANDMARC trial). Endocrinology Diabetes & Metabolism. 6(5). e422–e422. 1 indexed citations

Das, Ashok Kumar, Sanjay Kalra, Shashank Joshi, et al.. (2023). Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus. Endocrinology Diabetes & Metabolism. 6(2). e404–e404. 1 indexed citations

Sethi, Bipin, et al.. (2023). Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study. Drugs - Real World Outcomes. 11(1). 81–90. 2 indexed citations

Sethi, Bipin, et al.. (2022). Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus. Diabetes Therapy. 13(8). 1409–1481. 1 indexed citations

Mohan, Viswanathan, Abdul Hamid Zargar, Manoj Chawla, et al.. (2021). Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study. Diabetes Metabolic Syndrome and Obesity. Volume 14. 2925–2933. 12 indexed citations

Sethi, Bipin, et al.. (2020). Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records. Drugs - Real World Outcomes. 7(4). 271–279. 4 indexed citations

Khunti, Kamlesh, Viswanathan Mohan, Sunil Jain, et al.. (2017). Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program. Diabetes Therapy. 8(3). 673–682. 1 indexed citations

Mirasol, Roberto, K. C. B. Tan, Chaicharn Deerochanawong, et al.. (2017). A Consensus of Key Opinion Leaders on the Management of Pre-diabetes in the Asia-Pacific Region. Journal of the ASEAN Federation of Endocrine Societies. 32(1). 6–12. 7 indexed citations

10.

Sethi, Bipin, et al.. (2017). The thyroid registry: Clinical and hormonal characteristics of adult indian patients with hypothyroidism. Indian Journal of Endocrinology and Metabolism. 21(2). 302–302. 18 indexed citations

11.

Sethi, Bipin, et al.. (2016). SGLT2 Inhibitor and DPP4 Inhibitor Co-Administration In Type 2Diabetes -Are We Near The Promised Land?. 4(1).

12.

Mohan, Viswanathan, Bipin Sethi, Ganapathi Bantwal, et al.. (2016). Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India. Indian Journal of Endocrinology and Metabolism. 20(3). 372–372. 18 indexed citations

13.

Sethi, Bipin. (2015). Trials and tribulations of managing type 1 diabetes. Indian Journal of Endocrinology and Metabolism. 19(7). 16–16.

14.

Aschner, Pablo, Bipin Sethi, Fernando Gómez‐Peralta, et al.. (2015). Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study. Journal of Diabetes and its Complications. 29(6). 838–845. 28 indexed citations

15.

Sethi, Bipin, et al.. (2014). Treat-to-target trials in diabetes. Indian Journal of Endocrinology and Metabolism. 18(2). 166–166. 15 indexed citations

16.

Joshi, Shashank, Banshi Saboo, Sameer Dani, et al.. (2011). Prevalence of Diagnosed and Undiagnosed Diabetes and Hypertension in India—Results from the Screening India's Twin Epidemic (SITE) Study. Diabetes Technology & Therapeutics. 14(1). 8–15. 123 indexed citations

17.

Russell‐Jones, David, Allan Vaag, O. Schmitz, et al.. (2009). Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia. 52(10). 2046–2055. 688 indexed citations breakdown →

18.

Sethi, Bipin, et al.. (2005). Serum calcineurin activity in relation to oxidative stress and glycemic control in type II diabetes mellitus. Clinical Biochemistry. 38(3). 218–222. 9 indexed citations

19.

Bhansali, Anil, et al.. (2005). Effect of Opiates on Growth Hormone Secretion in Acromegaly. Hormone and Metabolic Research. 37(7). 425–427. 11 indexed citations

20.

Dash, R J, et al.. (1989). FAILURE OF LONG‐TERM CYPROHEPTADINE THERAPY IN LOWERING GROWTH HORMONE LEVELS IN ACROMEGALY. Clinical Endocrinology. 30(6). 639–644. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact